Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “OLEIC ACID”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,405 records · Page 78Linked to original sources

Final report on the safety assessment of Cocoyl Sarcosine, Lauroyl Sarcosine, Myristoyl Sarcosine, Oleoyl Sarcosine, Stearoyl Sarcosine, Sodium Cocoyl Sarcosinate, Sodium Lauroyl Sarcosinate, Sodium Myristoyl Sarcosinate, Ammonium Cocoyl Sarcosinate, and Ammonium Lauroyl Sarcosinate.

This safety assessment addresses cosmetic ingredients that are N-acyl derivatives of sarcosine and are generally referred to as acyl sarcosines, and those that are salts, known generally as acyl sarcosinates. Previous assessments have addressed the safety of each of the fatty acids that appear in these acyl sarcosines and sarcosinates (Coconut Acid, Oleic Acid, Lauric Acid, and Myristic Acid). In each case the fatty acid was either safe for use or safe as used in cosmetic formulations. Acyl sarcosines are considered modified fatty acids with greater solubility and increased acidity of the carboxylic acid group compared to the parent fatty acid. They are used in a large number of cosmetic formulations as hair-conditioning agents and surfactant-cleansing agents. In soaps, concentrations are reported to be as high as 12.9%. These ingredients have low oral toxicity in rats. Although cytotoxic to Chinese hamster cells in culture, acyl sarcosines and sarcosinates are not mutagenic in those cells, nor in bacterial cells in culture. Carcinogenicity data were not available. These ingredients are nonirritating and nonsensitizing to animal and human skin, although they can enhance the penetration of other ingredients through the skin. For that reason, caution should be exhibited in formulating cosmetic products that contain these ingredients in combination with other ingredients whose safety is based on their lack of absorption or where dermal absorption is a concern (e.g., HC Yellow No. 4, Disperse Yellow 3). Because sarcosine can be nitrosated to form N-nitrososarcosine, a known animal carcinogen, these ingredients should not be used in cosmetic products in which N-nitroso compounds may be formed. With the above caveat, and based on the available data, it was concluded that these acyl sarcosines and sarcosinates are safe as used in rinse-off products. They may be safely used in leave-on products at concentrations up to 5%, the highest concentration tested in clinical irritation and sensitization studies. Oleoyl Sarcosine is used as a corrosion inhibitor in some aerosol products, at extremely low concentrations. In this circumstance, the ingredient is not being used as a cosmetic ingredient and this report is not intended to limit that use. Because of the absence of data on inhalation toxicity, however, it was concluded that the available data were not sufficient to support the safety of acyl sarcosines and sarcosinates as cosmetic ingredients in products where they are likely to be inhaled.

Administration, Inhalation↗

Effects of free fatty acid on polymerization of islet amyloid polypeptide (IAPP) in vitro and on amyloid fibril formation in cultivated isolated islets of transgenic mice overexpressing human IAPP.

BACKGROUND: Islet amyloid polypeptide (IAPP) is deposited as amyloid in the islets of Langerhans in type 2 diabetes. The mechanism behind the formation of the cytotoxic fibrils is unknown. Islet amyloid develops in a mouse IAPP null mouse strain that expresses human IAPP (+hIAPP/-mIAPP) after 9 months on a high-fat diet. Herein we investigate the effect that individual free fatty acids (FFAs) exert on formation of amyloid-like fibrils from synthetic IAPP and the effects of FFAs on IAPP polymerization in +hIAPP/-mIAPP islets cultivated in vitro. MATERIALS AND METHODS: In the study myristic acid, palmitic acid, stearic acid, oleic acid, and linoleic acid were used together with albumin. Thioflavin T (Th T) assay was used for quantification of amyloid-like fibrils. Islets were isolated from the +hIAPP/-mIAPP transgenic strain and cultured in the presence of the FFAs for 2 days. Immuno-electron microscopy was used for evaluation. RESULTS: The Th T assay showed that all studied FFAs potentiated fibril formation but that myristic acid revealed the highest capacity. In some cells from cultured islets, intragranular aggregates were present. These aggregates had a filamentous appearance and labeled with antibodies against IAPP. In some cells cultured in the presence of linoleic acid, large amounts of intracellular amyloid were present. Earlier, this has not been observed after such a short incubation period. CONCLUSIONS: Our studies suggest that FFAs can potentiate amyloid formation in vitro, probably without being integrated in the fibril. Cultivation of +hIAPP/-mIAPP transgenic mouse islets with FFAs results in altered morphology of the secretory granules with appearance of IAPP- immunoreactive fibrillar material. We suggest that such fibrillar material may seed extracellular amyloid formation after exocytosis.

Amyloid↗

Activation of peroxisome proliferator-activated receptor alpha in human endothelial cells increases plasminogen activator inhibitor type-1 expression.

OBJECTIVE: To investigate the effect of peroxisome proliferator-activated receptors (PPARs) activators on plasminogen activator inhibitor 1 (PAI-1) expression in human umbilical vein endothelial cells and elucidate a possible mechanism. METHODS: Human umbilical vein endothelial cells (HUVECs) were obtained from normal fetus, and cultured conventionally. Then the HUVEC were exposed to fatty acids and prostaglandin J(2) in varying concentrations with fresh media. RT-PCR and ELISA were used to determine the expression of PPAR and PAI-1 in HUVECs. Transient co-transfection of PAI-1 promoter and PPARalpha gene or PPARgamma gene to ECV304 was performed. RESULTS: PPARalpha, PPARdelta and PPARgamma mRNA in HUVECs were detected by RT-PCR. Treatment of HUVECs with PPARalpha and PPARgamma activators-linolenic acid, linoleic acid, oleic acid and prostaglandin J(2), but not with stearic acid could augment PAI-I mRNA expression and protein secretion in a concentration-dependent manner. Proportional induction of PAI-1 promoter activity was observed through increasing amounts of PPARalpha DNA in HUVECs through a transient gene transfection assay, although the mRNA expression of the 3 subtypes of PPAR with their activators were not changed compared with controls. CONCLUSIONS: HUVECs express PPARs. PPARs activators may increase PAI-1 expression in endothelial cells (EC). Although PPARs expression was not enhanced after being stimulated by their activators in EC, the functionally active PPARalpha is probably involved in regulating PAI-1 expression in EC.

Cells, Cultured↗

Membrane peroxidative damage enhancement by the ether lipid class of antineoplastic agents.

The ether lipid antineoplastic agents have no known interaction with DNA, but rather they appear to target membranes. The primary mechanism of action is unknown but effects on membrane biology are documented. We have studied the effect of two ether lipids on membrane lipids and examined the hypothesis that membrane peroxidative damage may be involved in their mechanism of action. With the use of cells having membranes enriched in polyunsaturated fatty acids of the omega-3 family of fatty acids, we have demonstrated that the prototypical ether lipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine and a thioether lipid analogue, 1-O-hexadecylmercapto-2-methoxymethyl-rac-glycero-3-phosphocholine , increase membrane lipid peroxidation and cytotoxicity in a time- and drug concentration-dependent manner. The oxidative cofactors Fe2+ and ascorbic acid were required. The pattern of cell death did not fully correspond to the peroxidation, since cofactors were required for peroxidation but not cytotoxicity. However, the rate of decrease in cell viability after exposure to the drug and cofactors corresponded to the peroxidation rate. In addition, when L1210 cells modified with the monounsaturated fatty acid oleic acid or unmodified cells were used, there was no ether lipid-enhanced peroxidation, and the cells were significantly less sensitive to the drug, with or without cofactors. The lipid-soluble antioxidant vitamin E inhibited 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine peroxidation and cytotoxicity in a concentration-dependent manner in the presence of cofactors but not consistently without them. Depletion of cellular glutathione content of L1210 cells using L-buthionine-(SR)-sulfoximine resulted in 40% augmentation of cofactor-facilitated cytotoxicity of 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine and a borderline effect on peroxidation. Another ether lipid, the thio compound 1-O-hexadecylmercapto-2-methoxymethyl-rac-glycero-3-phosphocholine , enhanced peroxidation in the presence of cofactors with kinetics corresponding to those of cytotoxicity. In the presence of ether lipid and cofactors the intensity of ascorbate free radical increased, consistent with oxidative stress. We conclude that the ether lipids stimulate membrane lipid peroxidation in a time- and drug concentration-dependent manner in the presence of oxidative cofactors. Even though peroxidation may not fully explain the cytotoxic effect of the ether lipid class of anticancer drugs, this observation provides further information on the nature of the membrane damage induced by the drugs. Since the ether lipids generate no known free radical intermediates directly, this suggests that membrane damage indirectly results in a process involving a peroxidative reaction.

Animals↗

[Topical administration of an hyperoxygenated fatty acid compound. Preventive and curative effects on pressure ulcer].

INTRODUCTION: Hyper-oxygenized acidic fats are a very useful topical use product for preventing pressure ulcers and to treat stage I pressure ulcers. Mepentol is a hyper-oxygenized acidic fats product (linoleic acid, gamma linolenic acid, oleic acid, palmitic acid, stearic acid, palmitoleic acid, arachidonic acid and eicosenoic acid) with extracts of Equisetum Avrense and Hypericum Perforatum. It works in three main facets: improve as is possible the epidermis's resistance, repair the damage to the epidermis produced by a prolonged pressure, and restore capillary circulation and counter arrest the effect of oxygen radicals produced during reactive hyperemia which are caused by periods of prolonged pressure. The exclusive formula, based on hyperoxygenized acidic fats and the above referred plant extracts, gives to Mepentol a demonstrated effectiveness, and also special features, like speed of action, great speed of topical absorption and a peculiar fragrance. PATIENTS, MATERIAL AND METHOD: In order to evaluate the tissue level effect of Mepentol, we carried out an experimental research project based on two different objectives: determine the effect at capillary circulation level in heels of healthy volunteers and in patients under risk of developing pressure ulcers, a well as in the treatment of stage I pressure ulcers in patients under high risk of developing pressure ulcers. To do so, the authors determined the capillary blood flow by means of a Doppler laser flow meter. RESULTS: After the application of a hyper-oxygenized acidic fats product, the authors noted an increase of 122.29 +/- 68.74% in flow units related to base values. The authors also observed an increase in microcirculation in heels of patients under high risk of developing pressure ulcers, as well as those who suffer from stage I lesions. These increases remain constant over long periods of time. COMMENTARY: Based on the tests carried out, Mepentol shows an undoubtable effect which improves local circulation in zones under risk of developing pressure ulcers as well as for stage I lesions; this supports the use of this product as a preventive measure against pressure ulcers and as treatment for stage I lesions.

Administration, Topical↗

[Effects of escharectomy during shock stage on the plasma lipid and serum free fatty acid levels in scalded rats].

OBJECTIVE: To investigate the influence of escharectomy during shock stage on plasma lipid and free fatty acid levels in scalded rats. METHODS: Thirty-two adult Wistar rats inflicted with 30% TBSA III degree scalding were employed as the model and were divided into normal control (NC), scalding control (SC) and treatment groups (T), and the latter was further divided into three sub groups according to the time of escharectomy, i.e. 8 postburn hour (PBHs) (T8), 24 PBHs (T24) and 96 PBHs (T96) groups. The rats were sacrificed at 168 PBHs. The postburn changes in the rat plasma lipid and free fatty acid levels were determined. RESULTS: 1) There was significant increase in serum triglyceride (TG), cholesterol (CHO), high density lipoprotein (HDL), low density lipoprotein (LDL), very low density lipoprotein (VLDL), apolipoprotein A (ApoA), apolipoprotein B (ApoB) and all the free fatty acids (FFAs) in the total serum FFAs excluding myristic acid (P < 0.05) at 168 PBHs in rats of all the T groups. 2) The serum levels of TG, CHO, ApoB, total FFA, lauric acid, palmitic acid, zoomaric acid, oleic acid and linoleic acid in T8 and T24 groups were evidently lower than those in SC group (P < 0.05). The plasma levels of VLDL, stearic acid and arachidonic acid in T8 were obviously lower than those in SC group (P < 0.05); 3) In T96 group, the serum levels of ApoB and lauric acid were significantly lower than those in SC group (P < 0.05), but all the other indices remained higher than those before injury. CONCLUSION: There was enhanced fat mobilization after severe burn injury. Escharectomy during shock stage might decrease fat mobilization, which was beneficial to the restoration of normal lipid metabolism.

Animals↗

[Cardiovascular effects of omega-3-fatty acids and alternatives to increase their intake].

Cardiovascular diseases are the main mortality cause in Europe, the USA and a great extent of Asia. There are several risk factors associated with cardiovascular diseases, such as increased total cholesterol, homocysteine and triglycerides, hypertension, diabetes, and reduced levels of HDL-cholesterol. Many of these risk factors are diet influenced. In spite of the great amount of foods enriched with n-3 fatty acids available at the market, the knowledge about the effects produced by regular intake of these foods still is a challenge in the majority of cases. It appears that intake of foods enriches with n-3 polyunsatured fatty acids is an option that may be effective in reducing risk factors for diseases, by substituting supplements without modifying consumer's alimentary habits. Also shown are the outcomes from a nutritional study undergone with a functional milk-bases food that contains n-3 fatty acids, oleic acid and vitamins.

Cardiovascular Diseases↗

Fatty acids and cyclooxygenase and lipoxygenase pathway inhibitors modulate inositol phosphate formation in pancreatic islets.

Isolated rat pancreatic islets prelabeled with myo-[3H]inositol respond to glucose and carbamylcholine with increased [3H] inositol phosphate (InsP) production. Prostaglandin E2 (PGE2) inhibits the effects of glucose and carbamylcholine on [3H]InsP production. Ionomycin reversed the effect of PGE2 on glucose-stimulated [3H]InsP production. The cyclooxygenase inhibitors indomethacin, ibuprofen, and eicosatetraynoic acid potentiated [3H]InsP production in response to 5 and 10 mM glucose but not to 17 mM glucose. Indomethacin did not affect the carbamylcholine response. Unsaturated fatty acids, including arachidonic acid, linolenic acid, eicosapentaenoic acid, oleic acid, and eicosatetraynoic acid, increased [3H]InsP production. Arachidonic acid potentiated [3H]InsP accumulation in response to low concentrations of glucose. Indomethacin potentiated the response to arachidonic acid. delta 9-Tetrahydrocannabinol, which mobilizes endogenous fatty acids, also potentiated glucose-stimulated [3H]InsP production. The lipoxygenase inhibitors BW755C and nordihydroguaiaretic acid inhibited [3H]InsP production in response to glucose, carbamylcholine, and fatty acids. Thus, PGE2 and endogenous cyclooxygenase products antagonize InsP production in islets, whereas fatty acids promote InsP accumulation.

4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyraz↗

[Effects of tumor promoters and related compounds on electric relations between giant cells of the salivary glands of Chironomus tentans larvae].

The action of 15 chemicals, being tumor-promoters and/or inhibitors of cell-to-cell communications in vitro upon electric relations between giant cells of salivary gland of the Chironomus tentans larvae are studied. It is shown that out of 11 compounds disturbing the intercellular contacts in this model, 10 chemicals are tumour-promoters (Aroclor 1254, butylated hydroxytoluene, di(ethylhexyl)phthalate, DDT, deoxycholic acid, lithocholic acid, oleic acid, anthralin, iodine-acetate, tween-80) and 1 compound (oleoyl-acetyl-glycerol) is not studied for the promoting activity. At the same time, two other tumor-promoters (phenobarbital and TPA) as well as two nontumor-promoters (phorbol and chlorpromazine) do not influence the electric relations. The possibilities of using the developed test-system for the screening of the tumour-promoters are discussed.

Animals↗

The effect of delta-9-tetrahydrocannabinol (delta-9-THC) on the release of nonesterified fatty acids in various brain structures.

There was studied the effect of repeated administration of delta-9-THC (10 mg/kg per os for two days) on the level of nonesterified fatty acids (NEFA) in the brain structures of laboratory rats. Palmitic acid, stearic acid, oleic acid and arachidonic acid were estimated with the help of gas chromatography after preliminary separation by TLC. After administration of delta-9-THC, the levels of NEFA decreased in the brain cortex, the brain stem and most in the hypothalamus. The NEFA decrease after delta-9-THC administration is in harmony with the functional inhibition of CNS, provoked by this substance.

Animals↗

[Nutrition in the prevention of ischemic heart disease].

The survey presents current knowledge on the role of nutrition in prevention of hypercholesterolemia and ischemic heart disease. From the standpoint of their role in atherogenesis, nutritional factors can be divided into protective and risk factors. The group of protective factors includes n-3 and n-6 polyunsaturated fatty acids, oleic acid, plant sterols, plant lecithins, some fiber components (e.g. pectin), plant proteins (e.g. soybean), vitamin C, vitamin E, magnesium, potassium, calcium, chromium, and selenium. The group of risk factors comprises saturated fatty acids, cholesterol, sucrose, sodium, vitamin D, and ethanol. After World War II the development of food consumption in Czechoslovakia resulted in an imbalanced state persisting for some decades now which is characterized by a high involvement of risk factors (high consumption of meat, sausages, animal fats, eggs, common salt, and alcoholic beverages) and by a low involvement of protective factors (low consumption of vegetables, fruit, potatoes, legumes, fish, and roughly milled grain). The imbalance of risk and protective factors in nutrition is conceivably one of the main causes of the extremely high mortality from cardiovascular diseases in Czechoslovakia. The current unfavorable trend in the rate of ischemic heart disease and in life expectancy of the population in Czechoslovakia can not be reversed without substantial changes in the composition of nutrition.

Coronary Disease↗

[Screening of drugs and chemicals by wide-bore capillary gas chromatography with flame ionization and nitrogen phosphorus detectors].

A method is presented for forensic toxicological screening of drugs and chemicals in blood and urine by wide-bore capillary gas chromatography with flame ionization detectors (FID) and nitrogen phosphorus detectors (NPD). The presence of drugs and chemicals in blood and urine specimens was confirmed by comparing these gas chromatograms with those of typical drug-free specimens. Peak components of drug-free specimens were piperidone, p-cresol, myristic acid, palmitic acid, stearic acid, oleic acid, linoleic acid, n-butylphthalate, bis (2-ethylhexyl) phthalate, squalene, cholesterol and two alcohols (unidentified) on FID chromatograms and were piperidone, indole, nicotine, cotinine, hydroxycotinine, caffeine and several unknown urine constituents on NPD chromatograms. In practical cases, the presence of drugs and chemicals in postmortem specimens was easily ascertained by the present method.

Adult↗

Induction of vimentin synthesis in a murine myeloma cell line by TPA is strongly dependent on the composition of the cell culture medium.

MPC-11 mouse plasmacytoma cells virtually lacking intermediate filament (IF) proteins can be induced to synthesize and accumulate the IF protein vimentin by treatment with the tumor promoting phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA). Like MPC-11 cells, X63-Ag8.6.5.3 mouse myeloma cells (Ag8) proved to be vimentin-negative, as assayed by immunoblotting of whole cellular protein using goat antiserum to vimentin and [125I]protein A. Vimentin synthesis could be elicited by a TPA concentration as low as 10(-9) M in cells grown in HB-102 serum-free medium. Transfer of these cells to medium containing 15% fetal calf cerum (FCS) greatly reduced the ability of these cells to synthesize vimentin upon TPA treatment. After 50 generations of culture in the presence of FCS, induction of vimentin synthesis was barely detectable even at a TPA concentration of 10(-6) M. Addition of FCS to cells grown in serum-free medium partially suppressed vimentin induction by TPA. This suppression seems to be due, at least in part, to nondialyzable, heat-sensitive components of FCS, since the dialyzable fraction even enhanced vimentin induction by TPA. When cells grown in the presence of FCS were transferred back to serum-free medium, their ability to synthesize vimentin in response to TPA treatment was readily restored. The individual components of serum-free medium which proved to support vimentin induction by TPA were insulin and the unsaturated fatty acids oleic acid and linoleic acid. An even stronger TPA response could be elicited by a combination of these components.(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗

Identification of a novel insulin-sensitive glycophospholipid from H35 hepatoma cells.

This study identifies and partially characterizes an insulin-sensitive glycophospholipid in H35 hepatoma cells. The incorporation of [3H]glucosamine into cell lipids was investigated. A major labeled lipid was purified by sequential thin layer chromatography using first an acid followed by a basic solvent system. After hydrochloric acid hydrolysis and sugar analysis by thin layer chromatography, 80% of the radioactivity in the purified lipid was found to comigrate with glucosamine. H35 cells were prelabeled with [3H]glucosamine for either 4 or 24 h and treated with insulin causing a dose-dependent stimulation of turnover of the glycophospholipid which was detected within 1 min. The purified glycolipid was cleaved by nitrous acid deamination indicating that the glucosamine C-1 was linked to the lipid moiety through a glycosidic bond. [14C]Ethanolamine, [3H]inositol, and [3H]sorbitol were not incorporated into the purified glycolipid. The incorporation of various fatty acids into this glycolipid was also studied. [3H]Palmitate was found to be preferentially incorporated while myristic acid, stearic acid, oleic acid, linoleic acid, linolenic acid, and arachidonic acid were either not incorporated or incorporated less than 10% of palmitate. The purified glycolipid labeled with [3H]palmitate was cleaved by treatment with phospholipase A2 but was resistant to mild alkali hydrolysis suggesting the presence of a 1-hexadecyl,2-palmitoyl-glyceryl moiety in the purified lipid. Treatment of labeled glycophospholipid with phosphatidylinositol-specific phospholipase C from Staphylococcus aureus generated a compound migrating as 1-alkyl,2-acyl-glycerol and a polar head group with a size in the range from 800 to 3500. These findings coupled with the nitrous acid deamination demonstrate that glucosamine was covalently linked through a phosphodiester bond to the glyceryl moiety of the purified glycolipid. These findings suggest that insulin acts on this glycophospholipid by stimulating an insulin-sensitive phospholipase C. This unique glycophospholipid may play an important role in insulin action by serving as precursor of insulin-generated mediators.

Acetylation↗

Serum lipids and lipoproteins in hypothyroidism.

Obese strain (OS) chickens hatched in the NIU vivarium were observed, primarily with respect to serum lipid and lipoprotein parameters, over a period of 36 weeks. The hypothyroid birds began to show differences in total serum lipids as compared to non-OS controls as early as 4 weeks post-hatching. All lipaemic chickens displayed lack (or deficiency) of thyroid tissue. Although all the thyroid deficient chickens showed increases in serum lipids, they were individually highly variable with respect to both quantity of serum lipid and time of onset of severe lipaemia. Six of twenty four OS birds became severely hyperlipaemic. One of these displayed a level of serum lipid amounting to 323 mg/ml. The increased serum lipid consisted primarily of triglyceride and phospholipid and was not accompanied by corresponding increases in apoproteins B or A-I. However, because of its high content of palmitic acid, oleic acid and phospholipid, the bulk of the serum lipid in OS birds appeared to be derived from the liver rather than directly from the diet. It is concluded that sufficient phospholipid was present in the plasma to form micelles, thus reducing requirements for association of solubilizing apoproteins. Livers were considerably enlarged in hyperlipaemic birds, possibly to compensate for decreases in lipid synthesizing enzymes per unit mass of tissue. However, results of gamma-irradiation of OS chickens (showing exacerbation of hyperlipaemia) indicated that hyperlipaemia in OS birds may be largely due to widespread failure of the body's cells to utilize foodstuffs and of adipose tissue to store excessive amounts of fatty acids as triglyceride.

Animals↗

[Fatty acid metabolism in primary hyperlipoproteinemia (HLP) (author's transl)].

The fatty acid spectra of cholesterol ester and triglyceride fractions separated by thin-layer chromatography were analyzed by gas chromatography in the sera of 252 patients with primary HLP (with 53 cases of type IIa, 48 cases of type IIb, and 151 cases of type IV) and 60 healthy persons. Showing significantly increased values in the cholesterol ester fraction for HLP of types IIa and IIb as well as in the triglyceride fraction for HLP of types IIb and IV were palmitic acid, stearic acid, palmitoleic acid, oleic acid, and eicosatrienic acid. Significantly reduced percentages were obtained for linoleic acid, linolenic acid, arachidonic acid, and eicosapentaenic acid in the same fractions for these types. Possible causes include disturbances of the fatty acid metabolism in the liver, increased selective reesterification of fatty acids of the lipolytic process, and partially altered LCAT activity.

Adult↗

[Lipoproteins and fatty acids--hyperlipoproteinemia and arteriosclerosis].

At first on the basis of literature a short description of the interrelations between lipoprotein metabolism and fatty acid metabolism as well as hyperlipoproteinaemia on the one hand and arteriosclerotic-degenerative diseases of the coronary vessels on the other is given. Finally, the findings of gas-chromatographic analyses of the patterns of fatty acids of the cholesterol ester and triglyceride fractions of the serum of 252 patients with primary hyperlipoproteinaemia are represented. In contrast to persons with healthy metabolism increase of the proportions per cent of palmitic acid, stearic acid, palmitoleic acid, oleic acid, and eikosatrienic acid was shown and decrease of those ones of linoleic acid, linolenic acid, arachidonic acid, and eikosapentaic acid in the cholesterol ester fractions in hyperlipoproteinaemia type IIa and IIb and in the triglyceride fractions in hyperlipoproteinaemia type IIb and IV. The shifts within the patterns of fatty acids in hyperlipoproteinaemia are an expression of an atherogenic risk. Disturbances of the hepatogenic synthesis of fatty acids and oxydation of fatty acids, increased reesterification from the depot fat of mobilised fatty acids as well as a partially increased LCAT-activity are causally discussed.

Arteriosclerosis↗

[Lipid-reducing basic diet and serum fatty acid levels].

In 50 patients with primary hyperlipoproteinaemia during a 3 year treatment with lipid reducing metabolic basis diet in intervals of 4 months the composition of the cholesterol ester and triglyceride fatty acids of the serum was determined by means of gas chromatography. After 12--16 months in the hyperlipoproteinaemia type IIa (10 patients) in the cholesterol ester fraction, after 12 months in the hyperlipoproteinaemia type IIb (10 patients) in the cholesterol ester fraction and in the triglyceride fraction significant changes of the spectre of fatty acids developed. Palmitic acid, stearic acid, palmitoleic acid, oleic acid and eikosatrienic acid decreased, and linolic acid, linolenic acid, arachidonic acid and eikosapentaenic acid increased. In the course of the further therapy the precental proportions of the fatty acids did no more change. Triglyceride fatty acids in hyperlipoproteinaemia of type IIa and cholesterol ester fatty acids in hyperlipoproteinaemia of type IIb were not influenced. These metabolic effects of the metabolic basis diet on the spectres of fatty acids of cholesterol ester and triglyceride fractions in primary hyperlipoproteinaemia of type IIa, IIb and IV must not be seen only in their increased content of polyene fatty acids which influences the hepatogenic processes of synthesis and oxydation of fatty acids, but are traced back also to the reduced proportions of fat, mono- and disaccharide. With metabolic basis diet decreasing lipids alone we, however, did not succeed in normalising fully the composition of fatty acids, and the constellations of fatty acids of test persons with healthy metabolism were reached only approximately.

Cholesterol↗